Claudia Arce

1.1k total citations
17 papers, 880 citations indexed

About

Claudia Arce is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Claudia Arce has authored 17 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Claudia Arce's work include Epigenetics and DNA Methylation (5 papers), Breast Cancer Treatment Studies (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Claudia Arce is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Breast Cancer Treatment Studies (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Claudia Arce collaborates with scholars based in Mexico, Canada and France. Claudia Arce's co-authors include Myrna Candelaria, Alfonso Dueñas‐González, Lucely Cetina, Enrique Pérez‐Cárdenas, Lucía Taja‐Chayeb, Eduardo Cervera, Marcela Lizano, Óscar Arrieta, Enrique Bargalló and Fernando Lara-Medina and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Claudia Arce

16 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Arce Mexico 9 548 227 225 105 99 17 880
Dereck D. Amakye United Kingdom 13 718 1.3× 82 0.4× 341 1.5× 99 0.9× 130 1.3× 20 1.0k
Sophie Barrett United Kingdom 9 256 0.5× 161 0.7× 295 1.3× 40 0.4× 54 0.5× 18 660
Catalina Trejo‐Becerril Mexico 18 1.2k 2.1× 311 1.4× 258 1.1× 147 1.4× 122 1.2× 40 1.6k
Darlene Gibbon United States 15 375 0.7× 109 0.5× 325 1.4× 126 1.2× 36 0.4× 38 834
Silvia J. Serrano‐Gómez Colombia 12 494 0.9× 327 1.4× 349 1.6× 51 0.5× 102 1.0× 21 913
Eiichiro Tominaga Japan 24 648 1.2× 481 2.1× 275 1.2× 101 1.0× 112 1.1× 66 1.4k
Assaad Semaan United States 19 382 0.7× 244 1.1× 176 0.8× 109 1.0× 31 0.3× 29 892
Fu-Shing Liu Taiwan 13 313 0.6× 96 0.4× 201 0.9× 103 1.0× 47 0.5× 20 710
Luis T. Campos United States 13 201 0.4× 140 0.6× 441 2.0× 47 0.4× 77 0.8× 29 726
Matteo Ghilli Italy 15 247 0.5× 306 1.3× 308 1.4× 50 0.5× 82 0.8× 43 794

Countries citing papers authored by Claudia Arce

Since Specialization
Citations

This map shows the geographic impact of Claudia Arce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Arce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Arce more than expected).

Fields of papers citing papers by Claudia Arce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Arce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Arce. The network helps show where Claudia Arce may publish in the future.

Co-authorship network of co-authors of Claudia Arce

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Arce. A scholar is included among the top collaborators of Claudia Arce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Arce. Claudia Arce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mohar, Alejandro, Nancy Reynoso‐Noverón, Rosa María Álvarez-Gómez, et al.. (2024). Clinical characteristics of male patients with breast cancer in the Latino population. Breast Cancer Research and Treatment. 209(3). 629–635.
2.
Arce, Claudia, et al.. (2021). The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Frontiers in Oncology. 11. 660943–660943. 28 indexed citations
3.
Arce, Claudia, Lourdes Flores‐Luna, Nancy Reynoso‐Noverón, et al.. (2019). Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients. Breast Cancer Research and Treatment. 176(1). 243–249. 19 indexed citations
4.
5.
Arce, Claudia, et al.. (2012). Combination treatment with aromatase inhibitor and capecitabine as first- or second-line treatment in metastatic breast cancer.. Journal of Clinical Oncology. 30(15_suppl). e11016–e11016. 5 indexed citations
6.
Lara-Medina, Fernando, Víctor M. Pérez-Sánchez, David Saavedra-Pérez, et al.. (2011). Triple‐negative breast cancer in Hispanic patients. Cancer. 117(16). 3658–3669. 169 indexed citations
7.
Arce, Claudia, et al.. (2011). Phase II open, single-arm trial: Cisplatin combined with paclitaxel and doxorubicin in operable or locally advanced triple-negative breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 1135–1135. 2 indexed citations
8.
Candelaria, Myrna, Dolores Gallardo‐Rincón, Claudia Arce, et al.. (2007). A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Annals of Oncology. 18(9). 1529–1538. 202 indexed citations
9.
Candelaria, Myrna, Dolores Gallardo‐Rincón, Claudia Arce, et al.. (2007). A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. BMC Cancer. 7(S1). 2 indexed citations
10.
Arce, Claudia, Carlos Pérez‐Plasencia, Aurora González‐Fierro, et al.. (2007). A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer. BMC Cancer. 7(S1). 9 indexed citations
11.
Arce, Claudia, Carlos Pérez‐Plasencia, Aurora González‐Fierro, et al.. (2006). A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer. PLoS ONE. 1(1). e98–e98. 118 indexed citations
12.
Arce, Claudia, et al.. (2006). Hydralazine target: From blood vessels to the epigenome. Journal of Translational Medicine. 4(1). 10–10. 89 indexed citations
13.
Arce, Claudia, et al.. (2006). Conferencia Internacional «El uso y transformación del espacio en América precolonial: hacia comprensiones sociales». Bulletin de l’Institut français d’études andines. 35 (2). 233–234. 3 indexed citations
14.
Arce, Claudia, et al.. (2005). Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World Journal of Surgical Oncology. 3(1). 35–35. 43 indexed citations
15.
Dueñas‐González, Alfonso, Marcela Lizano, Myrna Candelaria, et al.. (2005). Epigenetics of cervical cancer. An overview and therapeutic perspectives. Molecular Cancer. 4(1). 38–38. 185 indexed citations
16.
Meza–Junco, Judith, et al.. (2005). Phase-II trial of thalidomide for patients with metastatic renal cell carcinoma (RCC). Journal of Clinical Oncology. 23(16_suppl). 4761–4761. 2 indexed citations
17.
Lara, Fernando M., et al.. (2005). [Gestational trophoblastic disease. Experience at National Institute of Cancerology].. PubMed. 73(6). 308–14. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dereck D. Amakye Breakdown of academic impact, for papers by Sophie Barrett Breakdown of academic impact, for papers by Catalina Trejo‐Becerril Breakdown of academic impact, for papers by Darlene Gibbon Breakdown of academic impact, for papers by Silvia J. Serrano‐Gómez Breakdown of academic impact, for papers by Eiichiro Tominaga Breakdown of academic impact, for papers by Assaad Semaan Breakdown of academic impact, for papers by Fu-Shing Liu Breakdown of academic impact, for papers by Luis T. Campos Breakdown of academic impact, for papers by Matteo Ghilli
Rankless by CCL
2026